Chou, S., Alain, S., Cervera, C., Chemaly, R. F., Kotton, C. N., Lundgren, J., Papanicolaou, G. A., Pereira, M. R., Wu, J. J., Murray, R. A., Buss, N. E., & Fournier, M. (2023). Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. The Journal of Infectious Diseases, 229(2), 413–421. https://doi.org/10.1093/infdis/jiad293

Shao, D., Pena, O., Sekulic, M., Valdez Imbert, R., Vegivinti, C. T. R., & Jim, B. (2023). Secondary haemophagocytic lymphohistiocytosis in a patient with new-onset systemic lupus erythematosus: the challenges of timely diagnosis and successful treatment. BMJ Case Reports, 16(7), e252938. https://doi.org/10.1136/bcr-2022-252938

Kelly, N. K., Gómez-Olivé, F. X., Wagner, L. D., Aiello, A. E., Kahn, K., Pettifor, A., & Stoner, M. C. D. (2023). Intimate partner violence is associated with cytomegalovirus among young women in rural South Africa: An HPTN 068 analysis. Global Public Health, 18(1). https://doi.org/10.1080/17441692.2023.2258962

Golob, S., Batra, J., DeFilippis, E. M., Uriel, M., Carey, M., Gaine, M., Mabasa, A., Fried, J., Raikelkar, J., Restaino, S., Hi Lee, S., Latif, F., Yuzefpolskaya, M., Colombo, P. C., Choe, J., Majure, D., Jennings, D., Pereira, M. R., Clerkin, K., … Uriel, N. (2022). Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients. Clinical Transplantation, 36(12). Portico. https://doi.org/10.1111/ctr.14808